These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 33183383)
1. Obesity and the increased risk for COVID-19: mechanisms and nutritional management. Morais AHA; Passos TS; de Lima Vale SH; da Silva Maia JK; Maciel BLL Nutr Res Rev; 2021 Dec; 34(2):209-221. PubMed ID: 33183383 [TBL] [Abstract][Full Text] [Related]
6. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265 [TBL] [Abstract][Full Text] [Related]
7. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection. Huizinga GP; Singer BH; Singer K Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654 [TBL] [Abstract][Full Text] [Related]
8. Obesity as a risk factor for COVID-19: an overview. Alberca RW; Oliveira LM; Branco ACCC; Pereira NZ; Sato MN Crit Rev Food Sci Nutr; 2021; 61(13):2262-2276. PubMed ID: 32539446 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Obesity: Overlapping of Two Pandemics. Gammone MA; D'Orazio N Obes Facts; 2021; 14(6):579-585. PubMed ID: 34569546 [TBL] [Abstract][Full Text] [Related]
10. The Impact of Obesity on SARS-CoV-2 Pandemic Mortality Risk. Li Z; Surampudi V; Heber D Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684447 [TBL] [Abstract][Full Text] [Related]
11. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Stefan N; Birkenfeld AL; Schulze MB Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538 [TBL] [Abstract][Full Text] [Related]
12. Is obesity the missing link between COVID-19 severity and air pollution? Lubrano C; Risi R; Masi D; Gnessi L; Colao A Environ Pollut; 2020 Nov; 266(Pt 3):115327. PubMed ID: 32771867 [TBL] [Abstract][Full Text] [Related]
13. The Centrality of Obesity in the Course of Severe COVID-19. Liu D; Zhang T; Wang Y; Xia L Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Sharma JR; Yadav UCS Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701 [TBL] [Abstract][Full Text] [Related]
15. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022 [TBL] [Abstract][Full Text] [Related]
16. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity. Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087 [TBL] [Abstract][Full Text] [Related]
17. [Obesity and COVID-19 : Mechanisms involved in the collusion of two pandemics]. Favre L; Pantet O; Papadimitriou Olivgeris M Rev Med Suisse; 2021 Mar; 17(731):558-563. PubMed ID: 33760416 [TBL] [Abstract][Full Text] [Related]
18. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289 [TBL] [Abstract][Full Text] [Related]
19. The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet? Paoli A; Gorini S; Caprio M J Transl Med; 2020 Nov; 18(1):441. PubMed ID: 33218357 [TBL] [Abstract][Full Text] [Related]
20. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review. Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]